| Product Code: ETC6887157 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of Cyprus for adeno-associated virus vector manufacturing saw significant growth in 2024, with the top exporting countries being Metropolitan France, Belgium, Denmark, UK, and the USA. The market concentration, as measured by HHI, increased from high to very high in 2024, indicating a more consolidated market landscape. The impressive compound annual growth rate (CAGR) of 110.54% from 2020 to 2024 highlights the rapid expansion of this sector. Moreover, the robust growth rate of 52.24% from 2023 to 2024 demonstrates the continued momentum in the importation of AAV vectors for manufacturing in Cyprus.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Adeno Associated Virus Vector Manufacturing Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Adeno Associated Virus Vector Manufacturing Market - Industry Life Cycle |
3.4 Cyprus Adeno Associated Virus Vector Manufacturing Market - Porter's Five Forces |
3.5 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Scale of Operations, 2021 & 2031F |
3.6 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Therapeutic Area Scope, 2021 & 2031F |
3.7 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Method Scope, 2021 & 2031F |
4 Cyprus Adeno Associated Virus Vector Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cyprus Adeno Associated Virus Vector Manufacturing Market Trends |
6 Cyprus Adeno Associated Virus Vector Manufacturing Market, By Types |
6.1 Cyprus Adeno Associated Virus Vector Manufacturing Market, By Scale of Operations |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Scale of Operations, 2021- 2031F |
6.1.3 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.4 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Preclinical, 2021- 2031F |
6.1.5 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Commercial, 2021- 2031F |
6.2 Cyprus Adeno Associated Virus Vector Manufacturing Market, By Therapeutic Area Scope |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Hematological Diseases, 2021- 2031F |
6.2.3 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.4 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Genetic Disorders, 2021- 2031F |
6.2.5 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.6 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Ophthalmic Disorders, 2021- 2031F |
6.3 Cyprus Adeno Associated Virus Vector Manufacturing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3.3 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.3.4 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.4 Cyprus Adeno Associated Virus Vector Manufacturing Market, By Method Scope |
6.4.1 Overview and Analysis |
6.4.2 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By In Vitro, 2021- 2031F |
6.4.3 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By In Vivo, 2021- 2031F |
7 Cyprus Adeno Associated Virus Vector Manufacturing Market Import-Export Trade Statistics |
7.1 Cyprus Adeno Associated Virus Vector Manufacturing Market Export to Major Countries |
7.2 Cyprus Adeno Associated Virus Vector Manufacturing Market Imports from Major Countries |
8 Cyprus Adeno Associated Virus Vector Manufacturing Market Key Performance Indicators |
9 Cyprus Adeno Associated Virus Vector Manufacturing Market - Opportunity Assessment |
9.1 Cyprus Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Scale of Operations, 2021 & 2031F |
9.2 Cyprus Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Therapeutic Area Scope, 2021 & 2031F |
9.3 Cyprus Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Cyprus Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Method Scope, 2021 & 2031F |
10 Cyprus Adeno Associated Virus Vector Manufacturing Market - Competitive Landscape |
10.1 Cyprus Adeno Associated Virus Vector Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Adeno Associated Virus Vector Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |